Feb 2013
dr reddys
Financial Adviser
€ 27.3 million
Public Offer

Dr. Reddy’s

Dr. Reddy’s is a Mumbay and New York listed Indian generics company which strives to provide affordable and innovative medicines globally

  • OctoPlus is a Dutch listed company focused on the development of its proprietary drug formulation technologies, enhancing efficacy by applying liposomes and microspheres
  • Main transaction rationale for Dr. Reddy’s is to get access to the knowledge and capabilities of OctoPlus
  • Kempen & Co acted as financial adviser to Dr. Reddy’s